help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Franchimont, N.
Right arrow Articles by Canalis, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franchimont, N.
Right arrow Articles by Canalis, E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*12-O-TETRADECANOYLPHORBOL-13-ACETATE

Endocrinology, Vol 136, 5469-5475, Copyright © 1995 by Endocrine Society


ARTICLES

Platelet-derived growth factor stimulates the synthesis of interleukin- 6 in cells of the osteoblast lineage

N Franchimont and E Canalis
Department of Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut 06105, USA.

Platelet-derived growth factor (PDGF) increases bone resorption and the number of osteoclasts in calvarial sections, and it may regulate local cytokines involved in bone remodeling. Interleukin-6 (IL-6), a cytokine secreted by osteoblasts, osteoclasts, and stromal cells, is known to increase osteoclast recruitment. We tested the effects of PDGF on IL-6 expression in cultures of osteoblast-enriched cells from 22-day-old fetal rat calvariae (Ob cells). Treatment of Ob cells with PDGF BB caused a time- and dose-dependent induction of IL-6 messenger RNA (mRNA), as determined by Northern blot analysis. The effect was maximal after 1 h of treatment and was observed with PDGF BB at 0.3-3.3 nM. Treatment with PDGF BB for 24 h also increased IL-6 polypeptide levels in the culture medium, as determined by a specific bioassay. Although PDGF AA increased IL-6 mRNA levels, its effect was less pronounced than that of PDGF BB. Phorbol 12-myristate 13-acetate (PMA) induced IL-6 transcripts, and the effect of PDGF BB was inhibited in the presence of the protein kinase C (PKC) inhibitor, sangivamycin, or after down- regulation of PKC by PMA preincubation. Although forskolin increased IL- 6 mRNA levels, PDGF BB did not induce cAMP production in Ob cells. The calcium ionophore, ionomycin, enhanced IL-6 transcripts in Ob cells and the intracellular calcium chelator, 1,2-bis-(o-aminophenoxy)ethane- N,N,N',N'-tetraacetic acid tetra-(acetoxymethyl)-ester, inhibited the induction of IL-6 transcripts by PDGF BB, PMA, and PTH. In conclusion, PDGF BB stimulates IL-6 expression in Ob cells, a response that is PKC and calcium dependent. The increase in IL-6 expression may be relevant to the actions of PDGF BB on bone resorption.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
D. C. Lev, S. J. Kim, A. Onn, V. Stone, D.-H. Nam, S. Yazici, I. J. Fidler, and J. E. Price
Inhibition of Platelet-Derived Growth Factor Receptor Signaling Restricts the Growth of Human Breast Cancer in the Bone of Nude Mice
Clin. Cancer Res., January 1, 2005; 11(1): 306 - 314.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Guillen, P. Martinez, A. R. de Gortazar, M. E. Martinez, and P. Esbrit
Both N- and C-terminal Domains of Parathyroid Hormone-related Protein Increase Interleukin-6 by Nuclear Factor-kappa B Activation in Osteoblastic Cells
J. Biol. Chem., July 26, 2002; 277(31): 28109 - 28117.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. ValIn, C. Guillen, and P. Esbrit
C-Terminal Parathyroid Hormone-Related Protein (PTHrP) (107-139) Stimulates Intracellular Ca2+ through a Receptor Different from the Type 1 PTH/PTHrP Receptor in Osteoblastic Osteosarcoma UMR 106 Cells
Endocrinology, July 1, 2001; 142(7): 2752 - 2759.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. C. Manolagas
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis
Endocr. Rev., April 1, 2000; 21(2): 115 - 137.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. Miwa, O. Kozawa, H. Tokuda, and T. Uematsu
Mitogen-Activated Protein (MAP) Kinases Are Involved in Interleukin-1 (IL-1)-Induced IL-6 Synthesis in Osteoblasts: Modulation Not of p38 MAP Kinase, But of p42/p44 MAP Kinase by IL-1-Activated Protein Kinase C
Endocrinology, November 1, 1999; 140(11): 5120 - 5125.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
N. Franchimont, D. Durant, S. Rydziel, and E. Canalis
Platelet-derived Growth Factor Induces Interleukin-6 Transcription in Osteoblasts through the Activator Protein-1 Complex and Activating Transcription Factor-2
J. Biol. Chem., March 5, 1999; 274(10): 6783 - 6789.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Tokuda, O. Kozawa, A. Harada, K.-i. Isobe, and T. Uematsu
Triiodothyronine Modulates Interleukin-6 Synthesis in Osteoblasts: Inhibitions in Protein Kinase A and C Pathways
Endocrinology, March 1, 1998; 139(3): 1300 - 1305.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Kozawa, A. Suzuki, T. Kaida, H. Tokuda, and T. Uematsu
Tumor Necrosis Factor-alpha Autoregulates Interleukin-6 Synthesis via Activation of Protein Kinase C. FUNCTION OF SPHINGOSINE 1-PHOSPHATE AND PHOSPHATIDYLCHOLINE-SPECIFIC PHOSPHOLIPASE C
J. Biol. Chem., October 3, 1997; 272(40): 25099 - 25104.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Wakikawa, A. Shioi, M. Hino, M. Inaba, Y. Nishizawa, N. Tatsumi, H. Morii, and S. Otani
Thrombopoietin Inhibits in Vitro Osteoclastogenesis from Murine Bone Marrow Cells
Endocrinology, October 1, 1997; 138(10): 4160 - 4166.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Franchimont, D. Durant, and E. Canalis
Interleukin-6 and Its Soluble Receptor Regulate the Expression of Insulin-Like Growth Factor Binding Protein-5 in Osteoblast Cultures
Endocrinology, August 1, 1997; 138(8): 3380 - 3386.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Franchimont, S. Rydziel, A. M. Delany, and E. Canalis
Interleukin-6 and Its Soluble Receptor Cause a Marked Induction of Collagenase 3 Expression in Rat Osteoblast Cultures
J. Biol. Chem., May 2, 1997; 272(18): 12144 - 12150.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. M. Biasucci, A. Vitelli, G. Liuzzo, S. Altamura, G. Caligiuri, C. Monaco, A. G. Rebuzzi, G. Ciliberto, and A. Maseri
Elevated Levels of Interleukin-6 in Unstable Angina
Circulation, September 1, 1996; 94(5): 874 - 877.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society